FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891882743> ?p ?o ?g. }

• W2891882743 endingPage "3360" @default.
• W2891882743 startingPage "3352" @default.
• W2891882743 abstract "Purpose: Investigating surrogate endpoints shortening the time of therapeutic evaluation in nasopharyngeal carcinoma (NPC) after radical treatment. Patients and Methods: We retrospectively analyzed 830 patients receiving intensity-modulated radiotherapy (IMRT) from 2008 to 2010 and being stratified by the 8th edition of UICC/AJCC staging system and the plasma Epstein-Barr virus DNA (EBV DNA). The annual rates of overall survival (OS), progression-free survival (PFS), loco-regional recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) were sequentially calculated using the life table and compared by the McNemar method. Results: The time of shortening therapeutic evaluation by surrogate endpoints: OS, PFS, LRFS and DMFS could be shortened to 1-year (100% vs 100%, P=1) in patients with stage I; OS, PFS, LRFS and DMFS could be shortened to 3-year (96.9% vs 96.1%, P = 1; 94.6% vs 92.2%, P = 0.125; 96.9% vs 95.3%, P = 0.5) and 4-year (92.2% vs 91.2%, P = 0.125) in stage II; In the high EBV DNA group , OS and DMFS could be shortened to 1-year (100% vs 100%, P = 1;100% vs 100%, P = 0.25) in stage II; OS and PFS could be shortened to 3-year (94.3% vs 91.4%, P = 1;82.9% vs 74.3%, P = 0.25) in stage III; OS could be shortened to 4-year (75% vs 72.7%, P = 1) in stage IVA. Conclusions: The time of therapeutic evaluation could be shortened to <5-year in stages I-II patients. The year of surrogate endpoints could be ahead in stages II-IVA with high EBV DNA." @default.
• W2891882743 created "2018-09-27" @default.
• W2891882743 creator A5020871102 @default.
• W2891882743 creator A5040403651 @default.
• W2891882743 creator A5050708687 @default.
• W2891882743 creator A5055808161 @default.
• W2891882743 creator A5057823116 @default.
• W2891882743 creator A5063253432 @default.
• W2891882743 creator A5068654126 @default.
• W2891882743 creator A5074825028 @default.
• W2891882743 creator A5082496274 @default.
• W2891882743 creator A5085098264 @default.
• W2891882743 creator A5090111080 @default.
• W2891882743 creator A5091757625 @default.
• W2891882743 date "2018-01-01" @default.
• W2891882743 modified "2023-10-01" @default.
• W2891882743 title "Surrogate endpoints shortening the therapeutic evaluation duration for different subgroups of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A retrospective analysis of 830 patients stratified by the 8th edition of the UICC/AJCC staging system and plasma Epstein-Barr viral" @default.
• W2891882743 cites W1522297249 @default.
• W2891882743 cites W1968017437 @default.
• W2891882743 cites W1971577986 @default.
• W2891882743 cites W2011250897 @default.
• W2891882743 cites W2014401523 @default.
• W2891882743 cites W2024847643 @default.
• W2891882743 cites W2045579143 @default.
• W2891882743 cites W2059775855 @default.
• W2891882743 cites W2062231358 @default.
• W2891882743 cites W2077919953 @default.
• W2891882743 cites W2106787323 @default.
• W2891882743 cites W2111247797 @default.
• W2891882743 cites W2141689611 @default.
• W2891882743 cites W2146900413 @default.
• W2891882743 cites W2150434794 @default.
• W2891882743 cites W2161043223 @default.
• W2891882743 cites W2166602936 @default.
• W2891882743 cites W2167422856 @default.
• W2891882743 cites W2174306046 @default.
• W2891882743 cites W2186378789 @default.
• W2891882743 cites W2526747727 @default.
• W2891882743 cites W2561439576 @default.
• W2891882743 cites W2731426798 @default.
• W2891882743 cites W2742092685 @default.
• W2891882743 cites W4210983491 @default.
• W2891882743 doi "https://doi.org/10.7150/jca.25530" @default.
• W2891882743 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6160691" @default.
• W2891882743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30271496" @default.
• W2891882743 hasPublicationYear "2018" @default.
• W2891882743 type Work @default.
• W2891882743 sameAs 2891882743 @default.
• W2891882743 citedByCount "2" @default.
• W2891882743 countsByYear W28918827432020 @default.
• W2891882743 countsByYear W28918827432021 @default.
• W2891882743 crossrefType "journal-article" @default.
• W2891882743 hasAuthorship W2891882743A5020871102 @default.
• W2891882743 hasAuthorship W2891882743A5040403651 @default.
• W2891882743 hasAuthorship W2891882743A5050708687 @default.
• W2891882743 hasAuthorship W2891882743A5055808161 @default.
• W2891882743 hasAuthorship W2891882743A5057823116 @default.
• W2891882743 hasAuthorship W2891882743A5063253432 @default.
• W2891882743 hasAuthorship W2891882743A5068654126 @default.
• W2891882743 hasAuthorship W2891882743A5074825028 @default.
• W2891882743 hasAuthorship W2891882743A5082496274 @default.
• W2891882743 hasAuthorship W2891882743A5085098264 @default.
• W2891882743 hasAuthorship W2891882743A5090111080 @default.
• W2891882743 hasAuthorship W2891882743A5091757625 @default.
• W2891882743 hasBestOaLocation W28918827431 @default.
• W2891882743 hasConcept C105795698 @default.
• W2891882743 hasConcept C126322002 @default.
• W2891882743 hasConcept C141341695 @default.
• W2891882743 hasConcept C143998085 @default.
• W2891882743 hasConcept C146357865 @default.
• W2891882743 hasConcept C151730666 @default.
• W2891882743 hasConcept C167135981 @default.
• W2891882743 hasConcept C168563851 @default.
• W2891882743 hasConcept C186282968 @default.
• W2891882743 hasConcept C203092338 @default.
• W2891882743 hasConcept C2778997737 @default.
• W2891882743 hasConcept C2780739268 @default.
• W2891882743 hasConcept C3019894029 @default.
• W2891882743 hasConcept C33923547 @default.
• W2891882743 hasConcept C509974204 @default.
• W2891882743 hasConcept C71924100 @default.
• W2891882743 hasConcept C86803240 @default.
• W2891882743 hasConcept C90924648 @default.
• W2891882743 hasConceptScore W2891882743C105795698 @default.
• W2891882743 hasConceptScore W2891882743C126322002 @default.
• W2891882743 hasConceptScore W2891882743C141341695 @default.
• W2891882743 hasConceptScore W2891882743C143998085 @default.
• W2891882743 hasConceptScore W2891882743C146357865 @default.
• W2891882743 hasConceptScore W2891882743C151730666 @default.
• W2891882743 hasConceptScore W2891882743C167135981 @default.
• W2891882743 hasConceptScore W2891882743C168563851 @default.
• W2891882743 hasConceptScore W2891882743C186282968 @default.
• W2891882743 hasConceptScore W2891882743C203092338 @default.
• W2891882743 hasConceptScore W2891882743C2778997737 @default.
• W2891882743 hasConceptScore W2891882743C2780739268 @default.
• W2891882743 hasConceptScore W2891882743C3019894029 @default.
• W2891882743 hasConceptScore W2891882743C33923547 @default.
• W2891882743 hasConceptScore W2891882743C509974204 @default.

• next